Skip to main content
Back to Investors

Perceptive Advisors Portfolio Companies

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

Last updated: July 2026

Perceptive Advisors Investment Overview

Portfolio Companies
134
Total Invested
$9.5B
Average Investment
$101.5M

Perceptive Advisors's Most Recent Investments (2020+)

Company NameFoundedFunding StageAmountCity
Satellos Bioscience2025Post-IPO EquityUndisclosedToronto
Willow2022Series DUndisclosedMountain View
Forge Biologics2022Series CUndisclosedGrove City
Amylyx Pharmaceuticals2025Post-IPO EquityUndisclosedCambridge
IDEAYA Biosciences2026Post-IPO EquityUndisclosedSouth San Francisco
Nuvation Bio2026Post-IPO DebtUndisclosedNew York
Absci2026Post-IPO EquityUndisclosedVancouver
Neuron232026GrantUndisclosedSan Francisco
Orchestra BioMed2026Post-IPO DebtUndisclosedNew Hope
Relay Therapeutics2026Post-IPO EquityUndisclosedCambridge

Complete List of Perceptive Advisors Portfolio Companies (134)

Export
#CompanyStageAmountLocation
1Satellos BiosciencePost-IPO EquityUndisclosedToronto, Canada
2WillowSeries DUndisclosedMountain View, United States
3Forge BiologicsSeries CUndisclosedGrove City, United States
4Amylyx PharmaceuticalsPost-IPO EquityUndisclosedCambridge, United States
5IDEAYA BiosciencesPost-IPO EquityUndisclosedSouth San Francisco, United States
6Nuvation BioPost-IPO DebtUndisclosedNew York, United States
7AbsciPost-IPO EquityUndisclosedVancouver, United States
8Neuron23GrantUndisclosedSan Francisco, United States
9Orchestra BioMedPost-IPO DebtUndisclosedNew Hope, United States
10Relay TherapeuticsPost-IPO EquityUndisclosedCambridge, United States
Health CareMedicalPharmaceutical

Satellos Bioscience is a private regenerative medicine company developing novel therapeutics that stimulate or restore muscle regeneration.

Toronto, Canada
September 2025
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BabyCommercialConsumer ElectronicsHealth CareMedical DeviceWearablesWomen's

Willow is a women's healthcare company that develops pumping bras and breast pumps for women.

Mountain View, United States
September 2022
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Forge Biologics is a gene therapy development engine, enabling access to life changing gene therapy programs.

Grove City, United States
September 2022
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalNeurosciencePharmaceutical

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.

Cambridge, United States
September 2025
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareOncologyTherapeutics

IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.

South San Francisco, United States
June 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CarePharmaceutical

Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.

New York, United States
June 2026
Post-IPO Debt

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiopharmaBiotechnologyLife Science

Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins

Vancouver, United States
June 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

Health CareMedicalPharmaceutical

Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.

San Francisco, United States
June 2026
Grant

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalMedical Device

Orchestra BioMed is a biomedical innovation company that provides high-impact solutions for large unmet needs in procedure-based medicine.

New Hope, United States
May 2026
Post-IPO Debt

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.

Cambridge, United States
May 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Opus Genetics a clinical-stage biopharmaceutical company, develops and commercializes therapies for patients with ophthalmic disorders.

Farmington Hills, United States
April 2026
Post-IPO Debt

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth DiagnosticsOncologyPharmaceutical

Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.

South San Francisco, United States
April 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyGeneticsHealth CareMedical

Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.

Charlestown, United States
March 2026
$240.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiopharmaHealth CarePharmaceutical

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

Waltham, United States
March 2026
$100.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

ComputerHealth CareMedical Device

Hyperfine makes MRI accessible to every patient regardless of income or resources.

Guilford, United States
March 2026
$40.0M
Post Ipo Debt

Founder Contacts

19,000+ verified contacts

Health CareMedicalMedical Device

Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.

Campbell, United States
March 2026
$100.0M
Convertible Note

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiopharmaBiotechnologyNeurosciencePrecision Medicine

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

Los Altos, United States
March 2026
$120.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiopharmaHealth CareMedical

Kardigan develops personalized medicines using AI and data to target and treat the root causes of cardiovascular diseases.

South San Francisco, United States
October 2025
$254.0M
Series B

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Health CareInternet of ThingsMachine LearningNutritionSoftware

Twin Health is a metabolic health platform that offers sensors, AI to reverse, prevent and improve chronic metabolic diseases.

Mountain View, United States
August 2025
$53.0M
Series E

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceutical

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

Seattle, United States
July 2025
$100.0M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyDiabetesPharmaceutical

Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.

Vancouver, Canada
May 2025
$5.0M
Series B

Founder Contacts

19,000+ verified contacts

DiabetesHealth CareMedicalMedical DevicePersonal HealthWearables

Orpyx Medical Technologies develops sensor-based technologies and self-monitoring devices in medical and athletic spaces.

Calgary, Canada
September 2024
$20.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

GeneticsHealth CareLife ScienceMedical

Genome Medical is a telegenomics technology and services company allowing access to genomic-based medicine.

South San Francisco, United States
September 2024
$75.3M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Biotechnology

Bridge to Life is a supplier of preservation solutions globally with a focus on innovation in organ preservation and machine perfusion.

Northbrook, United States
August 2024
$1.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.

London, United Kingdom
May 2024
$120.0M
Series B

Founder Contacts

19,000+ verified contacts

Showing 1-25 of 134 portfolio companies

Frequently Asked Questions About Perceptive Advisors

How many companies has Perceptive Advisors invested in?

Perceptive Advisors has invested in 134 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Perceptive Advisors invest in?

Perceptive Advisors's top investment sectors include Health Care, Biotechnology, Medical, Pharmaceutical, Biopharma. The firm invests across 26 different industry categories.

What is Perceptive Advisors's largest investment?

Among tracked funding rounds, Kardigan received $254.0M in a Series B round. Perceptive Advisors's total known invested capital is $9.5B.

What is the average investment size for Perceptive Advisors?

Perceptive Advisors's average investment size is $101.5M across its portfolio of 134 companies.

What are Perceptive Advisors's most recent investments?

Recent Perceptive Advisors portfolio additions include Satellos Bioscience, Willow, Forge Biologics, Amylyx Pharmaceuticals, IDEAYA Biosciences. These companies were founded in 2020 or later.

Explore Other Top Investors

Discover portfolio companies of other leading venture capital firms and investors.

View All Investors